DelMar Pharmaceuticals, Inc. and Mountain Share Transfer, LLC, as Warrant Agent Warrant Agency Agreement Dated as of May __, 2019 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • May 23rd, 2019 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of May __, 2019 (“Agreement”), between DelMar Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and Mountain Share Transfer, LLC, a Georgia limited liability company (the “Warrant Agent”).
DELMAR PHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENTDealer-Manager Agreement • May 23rd, 2019 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE WARRANT DELMAR PHARMACEUTICALS, Inc.DelMar Pharmaceuticals, Inc. • May 23rd, 2019 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____________ 20241 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DelMar Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a H
COMMON STOCK PURCHASE WARRANT DELMAR PHARMACEUTICALS, INC.DelMar Pharmaceuticals, Inc. • May 23rd, 2019 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [____] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [__]1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [ ], 20242 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DelMar Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
